Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Oral Administration (if applicable): For oral formulations of AOD-9604 , research has shown bioavailability of approximately 40% in animal studies
delivery Wed, Jul 29Tue, Aug 4 COA included Same-day ship before 2PM PT Apple Pay Google Pay Visa Amex Discover Compound information Technical specifications for laboratory reference Molecular profile Research blend of cagrilintide with tirzepatide-class dual GIP/GLP-1 agonist for multi-receptor signaling studies in vitro
Third-Party Tested Every Batch All of the AHK-Cu batches require independent laboratory verification for purity, potency, and contaminant screening on every production run
Growth hormone receptor upregulation, measured at a 2.29-fold increase and ranking among the top 8 genes affected by BPC-157 treatment, further supports enhanced tissue regeneration
US$ 22.85
US$ 29.72
US$ 20.17
US$ 26.80
US$ 23.20
US$ 21.95
US$ 27.75
US$ 28.56
